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INTRODUCTION
T2* -weighted magnetic resonance imaging
(T2*WMRI) is widely known as a useful tool for
detecting microbleeds and thrombi in patients after
stroke (1-5). A new finding indicating ischemia on
3-tesla (3T) T2*WMRI, called the ‘ischemic vessel
sign’ (IVS), is hypointense signals of medullary and
cortical veins in the ischemic territory due to major
vessel occlusion or severe stenosis (6). Although,
IVS was previously reported to possibly indicate the
ischemic penumbra (6), no further reports have
been published. In fact, the natural course and
change of this sign in IVS after recanalization re-
main unclear. The aim of this study was to evaluate
the change in IVS in patients who did or did not re-
canalize by treatments. Our hypothesis is that IVS
may disappear or decrease after reperfusion if it re-
sulted from hypoperfusion. To test this, we studied
those patients who underwent urgent treatment con-
sisting of reperfusion of major vessel occlusion or
stenosis of carotid circulation.
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We had been treating patients with acute ischemic
stroke by only intravenous recombinant tissue plas-
minogen activator (IV rtPA) for approximately 3
years before 2009. All the patients who were treated
by IV rtPA underwent magnetic resonance imaging
(MRI) at the time of admission, shortly after and
about 24-72 hours after IV rtPA treatment. We often
identified recanalization failure after IV rtPA treat-
ment, allowing us to evaluate the natural course of
IVS over time in patients who did not recanalize.
METHODS
Patient selection, image analysis
We retrospectively investigated cases of acute
ischemic stroke caused by major vessel occlusion
or stenosis of the carotid circulations between Janu-
ary 2007 and December 2012. We obtained patients’
agreement about use of their laboratory, radiologi-
cal, clinical data as research data and official confer-
ence presentation. Present study was on the basis
of patents’ consent.
We included 26 patients who underwent MRI
scans at the time of admission or symptomatic wors-
ening, shortly after and 24-72 hours after treatment
during this period in this study. We divided our 26
patients into groups, that did (group 1, n=17), or
did not recanalize (group 2, n=9). A summary of
the intended patients is presented in the Table 1.
In group 1, we included patients who underwent
successful treatments such as carotid artery stent-
ing, percutaneous transluminal angioplasty (PTA)
or IV rtPA, for recanalization of stenotic or occlusive
lesions of carotid circulation. Patients who under-
went CAS or PTA were not treated by IV rtPA but
only endovascular treatment. Because patients who
underwent endovascular treatment had progression
several days after onset, we could not use rtPA. A
successful treatment was defined as thrombolysis
in cerebral infarction (TICI) grade 3 on conven-
tional angiography (7) or modified Mori grade 3 on
magnetic resonance angiography (MRA) (8). We
performed MRI evaluation over time as fellows : at
Table 1. Baseline characteristics
group 1 group 2
n=17 n=9 p
age, meanSD 75.59.2 75.413.2 1.000
gender, male, % 70 33 0.079
etiology, CES, % 35 67 0.048
Occlusion site, n
ICA 7 1 0.009
M1 7 6 0.079
M2 3 2 0.538
duration between onset to treatmentment, mininites 1750.1218.6 139.221.4 0.052
Duration between onset to first MRI, minitues 91.126.3 72.930.5 0.161
ASPECTS, median
Pre-treatment 7.71.1 7.30.9 0.560
Post- treatment 6.62.0 3.60.7 0.004
24-72 hrs after treatment 6.52.0 3.30.9 0.005
IVS score
Pre-treatment 4.22.1 4.41.3 1.000
Post- treatment 1.41.6 3.61.4 0.005
24-72 hrs after rtPA 0.20.4 0.40.3 0.506
NIHSS
initial 11.86.7 18.06.4 0.048
at the time of discharge 6.95.5 16.44.4 0.001
mRS at the time of discharge 2.51.6 4.01.4 0.041
EVT, endovascular treatment ; ICA, internal carotid artery ; M1, lesion of horizontal segment of middle cerebral artery ; M2, lesion of
the sylvian segment of middle cerebral artery ; CES, cardioembolic stroke ; ASPECTS, Alberta stroke program early CT score on diffusion-
weighted image ; IVS, ischemic vessel sign ; NIHSS ; National Institute of Health stroke scale ; mRS, modified Rankin Scale
The duration between onset and first Magnetic resonance image (MRI) of group 1 was difficult to compare with that of group 2 because
we performed percutaneous transluminal angioplasty (PTA) or carotid artery stenting (CAS) for the patients with progression several
days after onset. We defined the duration of patients who underwent PTA or CAS as the duration between clinical progression we de-
tected and first MRI
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the time of admission or symptomatic worsening
(Pre-treatment), shortly after (Post-treatment) and
about 24-72 hours after the treatment. We studied
all of the MRI scans that were examined for in-
tended patients during hospitalization. In group 2,
patients with stenosis or occlusion of the major ves-
sels of the carotid circulation who did not recanal-
ize after IV rtPA confirmed by MRA shortly after IV
rtPA were included. No recanalization was defined
as modified Mori grade 0 and 1 on MRA.
We established a simple scoring system (IVS
score) to easily evaluate the presence of IVS. We
separated the middle cerebral artery (MCA) terri-
tory into 9 areas (cortical 4, medullary 5) accord-
ing to venous territory (9). When IVS was positive
in each area, we assigned one point for each, and
summed the points to get an IVS score (maximum,
9). We gave each patients an IVS score (Fig. 1) of
Pre-treatment, Post-treatment and 24-72 hours af-
ter treatment. A Single neurosurgeon (R.M.) and
neurologist (Y.T.) who were blinded to the patients’
information evaluated 3T T2*WMRI. We used mean
IVS score and ASPECTS that were evaluated by a
single neurosurgeon and neurologist. We also evalu-
ated the Alberta Stroke Program Early CT scores
(ASPECTS) (10) on diffusion-weighted images
(DWI) all of the MRI scans that were examined for
the intended patients and the clinical presentation
according to the National Institute of Health (NIH)
stroke scale of Pre-treatment and at the time of dis-
charge.
MRI evaluation
MRI scans were acquired on a 3T Signa EXITE
HD 3.0-T scanner (GE Healthcare, Milwaukee, WI,
USA). The scan parameters for standard DWI echo-
planar imaging included the following : TR, 6,000
ms ; TE, 70 ms ; b values, 0 and 1,000 s/mm2 ; field
of view, 24 cm ; acquisition matrix ; and EPI factor,
37. For T2-WI, they were as follows : TR of 3,500
ms and TE of 100 ms. For T2*WI gradient-echo,
the parameters were TR of 400 ms and TE of 30 ms
in the axial plane. The slice thickness was 7 mm.
Statistical analysis
Continuous variables are expressed as mean
standard deviation. Analyses of these variables
among groups were performed using the Mann-
Whitney U test, categorical variables were com-
pared among groups on univariate analyses using
the Fisher’s exact test, analyses of variables among
3 groups ; i.e. Pre-treatment, Post-treatment and 24-
72 hours after treatments, were performed using
Friedman test or Bonferroni correction. Statistical
significance was set at p0.05. All statistical analy-
ses were performed using the SPSS program, ver-
sion 20.0 for Windows 7 (SPSS, IBM Corporation).
Fig. 1. Ischemic vessel sign (IVS) on 3-T T2* -weighted magnetic resonance imaging
IVS was defined as hypointensity and vessel enlargement compared with the contralateral hemisphere. IVS score was defined as the
total number of lesions with hypointensity in the territory of the middle cerebral artery
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RESULTS
In group 1, we included 17 patients (age 75.5
9.2 ; 12 males, and 5 females) with major vessel oc-
clusion or stenosis who underwent recanalization
by endovascular treatment or IV rtPA. In group 2,
we included 9 patients (age 75.413.2 ; 3 males and
6 females) who did not recanalize by IV rtPA.
In group 1, the causative arteries included 7 ICA,
and 9 MCA (7 M1 : horizontal segment, 2 M2 :
sylvian segment). We performed CAS for all of the
ICA lesions and PTA for 2 MCA lesions and admin-
istered rtPA for 5 M1 and 3 M2. After recanaliza-
tion, the IVS tended to decrease. The mean IVS
score before the procedure was 4.2, whereas that
after the procedure was 1.4 (p=0.030, Fig. 2). The
mean IVS 24-72 hours after the procedure was 0.2
(Pre-treatment vs. 24-72 hours after treatment, p=
0.015, Fig. 2). In contrast, the ASPECTS score did
not differ before and after treatment (Pre-treat-
ment vs. Post-treatment, 7.7 vs. 6.6, p=0.102, Fig.
3). Clinical presentations expressed according to
the NIH stroke scale, improved during hospitaliza-
tion (Pre-treatment vs. at the time of discharge, 11.8
vs. 6.9, p=0.003). In group 2, causative arteries in-
cluded 2 M2 and 6 M1 and 1 ICA. The median IVS
score of Pre-treatment, Post-treatment and about
24-72 hours after treatment were 4.4, 3.6 and 0.4.
The ASPECTS scores in group 2 tended to be worse
(Pre-treatment vs. Post-treatment, 7.3 vs. 3.6, p=
0.021, Fig. 3), than those in group 1. This finding
meant that ischemic lesions became complete in-
farcts that were perfused by occlusive arteries 24-
72 hours after IV rtPA administration in group 2.
NIH stroke scale did not differ between before IV
rtPA and at the time of discharge (Pre-treatment
vs. at the time of discharge ; 18.0 vs. 16.4, p=0.404,
Table 1). In addition, NIH stroke scale at the time
of discharge significantly differed between group 1
and 2 (group 1 vs. group 2, 6.9 vs. 16.4, p0.001,
Fig. 4). Representative cases in group 1 are shown
in Fig. 5, and one from group 2 was in Fig. 6.
Fig. 2. Comparison of ischemic vessel sign (IVS) between the
recanalization and no revascularization groups
Pre-IVS, IVS before treatment ; Post-IVS, IVS shortly after treat-
ment ; Last - IVS, IVS 24-72 hours after treatment
Fig. 3. Comparison of Alberta Stroke Program Early CT scores
(ASPECTS) between the recanalization and no revascularization
groups
PreASPECTS, ASPECTS on diffusion-weighted image (DWI)
before treatment ; PostASPECTS, ASPECTS on DWI shortly af-
ter treatment ; LastASPECTS, ASPECTS 24-72 hours after treat-
ment
Fig. 4. Comparison of National Institute of Health stroke scale
between the recanalization and no revascularization groups
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No patients in group 1 and 2 had severe compli-
cations such as hyperperfusion syndrome, proce-
dural complications (distal embolization that pre-
sented symptoms or dissection, hematoma that
needed treatment at puncture site (11-14) or symp-
tomatic intracranial hemorrhage (15-18)).
DISCUSSIONS
This study showed that patients with major ves-
sel occlusion or stenosis who have high-grade reper-
fusion flow after treatment were manifested decre-
ment of IVS, whereas those patients who did not
Fig. 5. Representative case from group 1
A 76-year-old man, had left hemiparesis and dysarthria as well as progressive symptoms under medical treatment due to right inter-
nal carotid artery stenosis. We performed carotid artery stenting (CAS) for the lesion. Hypointense signals in the territory of ischemia
disappeared after CAS. IVS score was 3, and ASPECTS was 9 before treatment. After treatment, IVS score was 0, and ASPECTS was 9.
The white circle shows IVS in B. A, B and C : diffusion-weighted imaging (DWI), T2*weighted imaging (T2*WI), and magnetic reso-
nance angiography at the time of the worsening, C, D and E : DWI, T2*WI and MRA after CAS
Fig. 6. Representative case of group 3
A 64-year-old man had left hemiparesis, dysarthria and hemispatial neglect. The administration od recombinant tissue plasminogen
activator (rtPA) resulted in failed recanalization. The white circle shows IVS in B. The IVS disappeared in the territory of complete in-
farction on diffusion-weighted imaging (DWI, D). IVS score was 4, and ASPECTS was 10 before treatment. After treatment, IVS score
was 0, and ASPECTS was 2. A, B and C : diffusion-weighted imaging (DWI), T2*weighted imaging (T2*WI), and magnetic resonance
angiography at the time of the worsening, C, D and E : DWI, T2*WI and MRA shortly after rtPA administration
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recanalize showed no decrement of IVS. The dec-
rement of IVS after treatment may be associated
with improved hemodynamic compromised status.
However, a natural course of IVS was not reported
previously. In this study, a natural course of IVS may
be shown as change of IVS in group 2. IVS also de-
creased in patients with low ASPECTS score caused
by complete infarction. Our findings may suggest
that the presence of IVS is associated with hypoper-
fusion and matched perfusion after ischemia may
contribute to the disappearance of IVS. IVS would
be useful for evaluating the extensive ischemia due
to major vessel occlusion and may be correlated
with the blood-oxygen-level-dependent (BOLD) ef-
fect due to increased deoxyhemoglobin (19-21). In
the area where we can observe IVS, the deoxyhemo-
globin level in veins is high and hypointense signals
are detected on T2*WMRI (21). IVS may be a pre-
dictor of misery perfusion and imminent infarction
(22).
IVS could also be reversible by recanalization ;
Liu et al. (22) observed decreased numbers of hy-
perintense vessels (HV) on fluid attenuated inver-
sion recovery (FLAIR) images after endovascular
recanalization of symptomatic ICA occlusion. A post-
operative decrease in HV can be considered as a
marker for hemodynamic improvement. Hohenhaus
et al. (23) reported on FLAIR vascular hyperinten-
sities (FVH) in acute ICA and MCA infarcts, which
indicates larger ischemic areas in the brain and can
be a marker for mismatch and stroke severity. FVH
and IVS might regress in the same way, after reca-
nalization. FVH is an arterial sign and means arte-
rial flow insufficiency (24). In contrast, IVS may be a
venous sign, and IVS changes may represent change
of cerebral oxygen metabolism associated with hy-
poperfusion, reperfusion after hypoperfusion or com-
plete infarction after hypoperfusion (25, 26).
There are limitations in this study. We did not
evaluate the perfusion images of the certain patients.
Morita et al. (6) reported area with IVS appeared in
hypoperfused area on flow-sensitive alternating in-
version recovery images. An actual perfusion in
the area with IVS was not examined to determine
whether hypoperfusion improved after recanaliza-
tion.
In conclusion, IVS may be a useful sign for de-
tecting extensive ischemia and indicate reversibil-
ity. IVS can be a parameter of misery perfusion and
an important factor to detect the patients who have
an indication of treatment for recanalization. Reper-
fusion is useful for preventing further progression
and to improve clinical symptoms of patients with
acute ischemic stroke, who have IVS and high
ASPECTS scores.
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